INHALANT DISPENSING SYSTEM AND APPARATUS WITH BINARY DOSING

TECHNICAL FIELD

The present invention relates to inhalation devices, and more specifically to systems and apparatus for controlling and monitoring the administration of an inhalant using such devices.

BACKGROUND

There are various forms of inhalation devices for converting a medicine or other substance into a vapor or mist and delivering the vaporized substance to the lungs for inhalation. One type of device is the vaporizer, or vape, which electrically heats a liquid substance into a vapor upon activation and delivers the vapor through a mouthpiece for inhalation. For example, a typical vaporizer may include (1) a storage compartment for holding a solution to be vaporized, (2) an atomizer or other heating element for vaporizing the liquid, (3) a power source, such as, for example, a rechargeable lithium-ion battery, for powering the atomizer and/or delivery system, and (4) a mouthpiece to enable inhalation of the vapor. When a button is pressed, the heating element fires or activates to atomize or vaporize the solution as it is drawn across the heating element. Suction pressure is simultaneously supplied by the user at the mouthpiece, first pulling the solution across the heating element and then pulling the vaporized liquid through a barrel or delivery tube and out through the mouthpiece.

Another type of inhalation device is the inhaler, or puffer, which has traditionally been used for delivering medication into the body via the lungs, mainly for the treatment of asthma and chronic obstructive pulmonary disease. Inhalers deliver a fixed or metered dose of medication, or other substance, in aerosol form upon activation. As an example, a typical inhaler may include a solution in a pressurized canister, a dispensing actuator, a metering valve that controls the amount of solution released when activated, and a mouthpiece for delivering the aerosolized solution to the user. One form of inhaler is a nebulizer, which breaks up a liquid solution into a mist as it is being dispensed. This may be done in various ways, such as by using ultrasonic waves, air pressure (an atomizer), or a heating element.

With the recent growth in vaping and the legalization of certain cannabis-based products, the demand for personal inhalation devices that can deliver cannabis and other plant-based substances or herbs has risen dramatically, for both medicinal and non-medical purposes. Such devices are typically portable, self-contained devices that come in varying sizes and/or forms, including, for example, slim cylindrical “vape pens” designed to look and feel like a traditional pen, elongated rectangular housings designed to fit easily within a pocket, wide rectangular housings designed to fit comfortably within a hand, vaporizers that look and operate like traditional, medicinal inhalers, dab devices designed for use with oil or wax cartridges, as well as many others.

Personal inhalation devices come in at least two varieties: wholly disposable or at least partially reusable. Among the reusable devices, some have replaceable substance delivery components (such as, e.g., cartridges, pods, canisters, etc.) that can be disposed once depleted and replaced, for example, with a new, pre-filled component. Other reusable devices have refillable substance delivery components that can be refilled by the user or by an appropriate dispensary. Reusable inhalation devices have the added advantage of allowing the user to change the makeup or composition of the substance being vaporized and inhaled. For example, cannabis-based products may come in different blends or strains, and a user may want different products at different times or for different needs (e.g., pain relief, sleep-inducement, relaxation, etc.).

However, many existing inhalation devices, or the cartridges, pods, canisters, and other substance delivery components being used therewith, lack the tools or mechanics to provide accurate dosing or metering of the vaporized substance being inhaled. For example, in conventional inhalers, the metering valve is rudimentary, and the amount of solution released with each use can be imprecise. And in conventional vaporizers, the amount of solution released will depend on how long the user intakes or pulls in air. Also, most existing inhalation devices will dispense each time there is actuation of the device, with no measurements or controls in place to track or limit, for example, the number and/or frequency of uses, or monitor the amount of solution being dispensed. These drawbacks present a serious chance for unintended abuse or misuse of the inhalant, particularly by less experienced or newer users.

SUMMARY OF THE INVENTION

Embodiments include an inhalant dispensing system comprising a cartridge, pod, or other substance delivery component coupled to an electronic inhalation device, wherein the system is configured to provide at least two user-selectable modes of operation: a beginner mode configured to control, monitor, measure, and/or track dosing for more inexperienced users, and an expert or professional mode configured to allow substantially uninhibited use for more experienced users. In some embodiments, a desired mode of operation may be selectively activated using the substance delivery component, such as, for example, based on how the component is attached to the inhalation device. In other embodiments, a desired mode of operation may be selectively activated using the electronic inhalation device, such as, for example, via an input selection device included on the inhalation device.

One exemplary embodiment provides an inhalant dispensing system comprising a substance delivery component comprising a substance to be vaporized, and a housing configured to be electrically coupled to the substance delivery component and comprising a power source configured to deliver power to the substance delivery component. The inhalant dispensing system further comprises a control system in communication with the power source and configured to implement a user-selected one of a plurality of operating modes, wherein a first one of the operating modes permits uninhibited usage of the substance delivery component, and a second one of the operating modes controls dosage during use of the substance delivery component.

According to aspects, the second operating mode controls dosage by stopping the delivery of power to the substance delivery component upon dispensing a threshold number of doses within a preset time period.

According to some aspects, the inhalant dispensing system further comprises a mode selection system configured to enable user selection of one of the plurality of operating modes and to send, to the control system, a signal indicating the user-selected mode. According to one aspect, the mode selection system is configured to determine the user-selected mode based on an orientation of the substance delivery component relative to the housing.

In some embodiments, the mode selection system comprises a first component disposed in the substance delivery component and a second component disposed in the housing, the mode selection system determining the orientation of the substance delivery component based on an arrangement of the first component relative to the second component. In one embodiment, the first component and the second component are configured to form an electrical connection when placed in contact with each other, and the mode selection system is configured to determine a first orientation for the substance delivery component upon detecting said electrical connection. In another embodiment, the second component comprises at least one sensor configured to detect a presence of the first component when the first component is within a close proximity of the second component, the mode selection system determining a first orientation for the substance delivery component upon detecting said presence.

According to some aspects, the substance delivery component further comprises a heating element configured to heat a selected amount of the substance into a vapor while receiving the power from the power source. wherein the second operating mode controls dosage by activating the heating element for a preset length of time corresponding to a single dose. In some embodiments, the second operating mode controls dosage by de-activating the heating element upon dispensing a threshold number of doses. In some embodiments, the housing further comprises an indicator system configured to deliver a notification to the user upon completion of the single dose when the second operating mode is selected.

According to some aspects, the substance delivery component further comprises a mouthpiece for dispensing the vaporized substance to the user.

Another exemplary embodiment provides an electronic inhalation device comprising a housing with a receptacle configured to receive a substance delivery component, the substance delivery component comprising a substance to be vaporized; a power source disposed within the housing and electrically coupled to the receptacle for delivering power to the substance delivery component; and a processor disposed within the housing and in communication with the power source, the processor being configured to implement a user-selected one of a plurality of operating modes, wherein a first one of the operating modes permits uninhibited usage of the substance delivery component, and a second one of the operating modes controls dosage during use of the substance delivery component.

According to some aspects, the second operating mode controls dosage by stopping delivery of power to the receptacle once a threshold number of doses has been dispensed within a preset time period.

According to some aspects, the second operating mode controls dosage by delivering power to the receptacle for a preset length of time corresponding to a single dose. In some embodiments, the housing further comprises an indicator system configured to deliver a first notification to the user upon completion of the single dose, when the second operating mode is selected. In some embodiments, the indicator system is further configured to deliver a second notification during user intake of the single dose, when the first operating mode is selected.

According to some aspects, the housing further comprises a mode selector configured to receive user selection of one of the plurality of operating modes and to send to the processor a signal indicating the user-selected mode. In some embodiments, the mode selector comprises at least one sensor disposed in the receptacle and configured to detect an orientation of the substance delivery component relative to the receptacle, the detected orientation indicating the user-selected mode. In other embodiments, the mode selector comprises a first contact component disposed in the receptacle and configured for electrical connection to a second contact component disposed in the substance delivery component when said substance delivery component is arranged in a first orientation within the receptacle, said electrical connection indicating the user-selected mode.

While certain features and embodiments are referenced above, these and other features and embodiments of the present invention will be, or will become, apparent to one having ordinary skill in the art upon examination of the following figures and detailed description. It is intended that all such additional embodiments and features included within this description, be within the scope of the present invention, and be protected by the accompanying claims.

BRIEF DESCRIPTION OF THE DRAWINGS

The present invention can be better understood with reference to the following drawings. The components in the drawings are not necessarily to scale, emphasis instead being placed upon clearly illustrating the principles of the present invention. In the drawings, like reference numerals designate corresponding parts throughout the several views.

FIG. 1A is a partially transparent, exploded view of an exemplary inhalant dispensing system in a first configuration, in accordance with certain embodiments.

FIG. 1B is a partially transparent, perspective view of the inhalant dispensing system of FIG. 1A after assembly in the first configuration, in accordance with certain embodiments.

FIG. 1C is a perspective view of an exemplary substance delivery component of the inhalant dispensing system of FIG. 1A, during rotation between the first configuration and a second configuration, in accordance with certain embodiments.

FIG. 1D is a partially transparent, exploded view of the inhalant dispensing system of FIG. 1A in the second configuration, in accordance with certain embodiments.

FIG. 1E is a partially transparent, perspective view of the inhalant dispensing system of FIG. 1D after assembly in the second configuration, in accordance with certain embodiments.

FIG. 2A is an exploded view of the inhalant dispensing system of FIG. 1A, in accordance with certain embodiments.

FIG. 2B is a partially exploded view of the inhalant dispensing system of FIG. 2A, in accordance with certain embodiments.

FIG. 2C is a perspective view of the inhalant dispensing system of FIG. 2A fully assembled, in accordance with certain embodiments.

FIG. 3 is a cross-sectional view of a top portion of the inhalant dispensing system of FIG. 2A, in accordance with certain embodiments.

FIG. 4 is a block diagram of an exemplary intelligent inhalant dispensing system, in accordance with certain embodiments.

DETAILED DESCRIPTION

The description that follows describes, illustrates and exemplifies one or more particular embodiments of the present invention in accordance with its principles. This description is not provided to limit the invention to the embodiments described herein, but rather to explain and teach the principles of the invention in such a way to enable one of ordinary skill in the art to understand these principles and, with that understanding, be able to apply them to practice not only the embodiments described herein, but also other embodiments that may come to mind in accordance with these principles. The scope of the present invention is intended to cover all such embodiments that may fall within the scope of the appended claims, either literally or under the doctrine of equivalents.

The term “substance delivery component” is used herein to denote any type of device that includes a storage compartment for holding a substance to be vaporized and is configured for coupling to an inhalation device. Exemplary substance delivery components include cartridges (e.g., dab or wax cartridges, oil cartridges, dry herb cartridges, etc.), pods (e.g., dab or wax pods, oil pods, dry herb pods, etc.), canisters (e.g., inhaler canisters, etc.), and the like. The substance stored in the substance delivery component can also vary and may include oils, concentrates, waxes, dry herbs, and other plant-based products. In some instances, the term “cartridge” is used for the sake of brevity but should be understood as including all types of substance delivery components. In addition to a storage compartment for storing the substance to be vaporized, the substance delivery component includes a heating element for heating the substance and/or a mouthpiece to facilitate inhalation, for example, as found in existing cartridges and pods.

The term “electronic inhalation device” or “electronic device” is used herein to denote any type of personal inhalant dispensing device that is configured to receive a substance delivery component and provide power to the same in order to vaporize the substance contained in the substance delivery component. Exemplary electronic inhalation devices include vape pens and other vaporizers, inhalers or puffers, devices configured for dabbing use, or other personal inhalant dispensers. The electronic inhalation device includes a coupling device for securing the substance delivery component therein and/or a battery for powering the substance delivery component.

The term “substance” is used herein to denote any type of product capable of being vaporized and inhaled by a user and is not limited to a particular consistency or format. For example, the substances may include various types of cannabis, tobacco, and other plant-based products, including blends and/or strains thereof, and may come in various forms, including, for example, a wax or other concentrate, an oil or other liquid solution, a dry herb, flower, or other solid, and others. The substances may also include vaporizable medicinal products.

Exemplary embodiments may include an intelligent inhalant dispensing system comprising a “smart” pod or other substance delivery component configured to provide information about the contents stored in the pod (e.g., exact type of strain, chemical makeup, or other substance identifying information), and a “smart” electronic inhalation device configured to obtain information from a smart pod installed therein and facilitate monitoring, measuring, controlling, and/or tracking usage of the pod or device. Each smart pod may contain information identifying the substance contained in a storage compartment of the pod, dosing information for that substance, and in some cases, heating profile information specific to the substance. The smart inhalation device may contain information specific to the user of the device, and may combine this information with the information from the smart pod to make dosing and administration decisions. For example, the smart inhalation device may include a dosage administration system configured to electronically monitor dosing and prevent excessive dosing, and a pod identification system configured to identify the cartridge being used and obtain and/or provide dosage information associated therewith. The electronic inhalation device may work in association with the smart pod to control dosing of the substance contained therein, monitor the user's inhalant consumption over time, provide the user with various information about the substance, such as, e.g., flavor profile, common side effects, heating profile, etc., and, in some cases, provide recommendations for new products or substances that the user may enjoy based on the user's consumption history. In some embodiments, the electronic inhalation device also includes a preparation system configured to monitor preparation of the substance to be vaporized (e.g., through shaking, heating temperature and/or time, etc.) and provide an indication when the substance is ready for use. One or more of the above features may require the use of wireless communication with a personal electronic device, such as, e.g., a smartphone. While some details of such an intelligent inhalant dispensing system are provided herein, additional details may be found in commonly-owned U.S. Non-provisional patent application Ser. No. 16/563,623, filed on Sep. 6, 2019, the contents of which are incorporated by reference herein in their entirety.

FIGS. 1A through 1E illustrate an exemplary inhalant dispensing system 100 configured to provide at least two user-selectable operating modes, namely a beginner mode configured to control, monitor, measure, and/or track dosing for more inexperienced users, and an expert or professional mode configured to allow substantially uninhibited use for more experienced users, in accordance with embodiments. The system 100 comprises a substance delivery component 102 and an electronic inhalation device 104 configured to receive the substance delivery component 102. One or more of the substance delivery component 102 and the electronic inhalation device 104 (also referred to therein as “electronic device”) includes components for enabling user-selection of a desired operating mode and for implementing the selected mode. In some embodiments, the inhalant dispensing system 100 is an “intelligent” system, as described above. For example, the substance delivery component 102 may be a “smart pod” or “smart cartridge” that has data available for interpretation, and in some cases, at least a memory capability. Likewise, the electronic inhalation device 104 may be a “smart” inhalation device that is configured to receive or interpret data provided by the smart pod, store information about the user, and use both for controlling, monitoring, and/or tracking usage of the device 104.

Portions of FIGS. 1A, 1B, 1D, and 1E are drawn with partially transparent surfaces to show components included within the substance delivery component 102 and within the electronic inhalation device 104, such as, for example, power source 105 included within the electronic inhalation device 104 for providing power to the substance delivery component 102.

In actuality, various surfaces of the inhalant dispensing system 100 may be opaque, or made of opaque or solid materials, while one or more other surfaces may be transparent or made of clear or transparent materials, as shown in FIGS. 2A through 2C. For example, FIG. 2B show the substance delivery component 102 as comprising a lower portion that is as at least partially transparent and an upper portion that is completely opaque, and show the electronic inhalation device 104 as being completely opaque. As shown in FIG. 2C, when the inhalant dispensing system 100 is assembled, all, or substantially all, of the system's outer or visible surfaces may be solid or opaque. It should be appreciated that other embodiments of the system 100 may have other combinations of opaque and clear surfaces, including, for example, completely transparent outer and inner surfaces or completely opaque outer and inner surfaces.

Though other shapes can be employed, the illustrated substance delivery component 102 (also referred to herein as “pod”) has a flattened shape, with an opening or mouthpiece 106 for dispensing an aerosol at a first end, and a substantially flat bottom 108 for coupling to the electronic inhalation device 104 at a second, opposing end. In other embodiments, for example, the substance delivery component 102 may have a cylindrical shape, a rectangular shape, or any other shape capable of coupling to the electronic device 104. A housing 110 extending between the first and second ends comprises a storage compartment 112 for containing a substance or solution to be converted into an aerosol prior to delivery via the mouthpiece 106. This conversion function may be performed by a converter 114, such as, for example, an atomizer or other heating element included in the pod 102. The mouthpiece 106 may be formed in a top cap 115 of the pod 102. In some embodiments, the top cap 115 may be removable for purposes of filling the solution compartment during manufacture, at a dispensary, or by the user prior to use.

FIG. 2A is an exploded view of the substance delivery component 102, with the storage compartment 112 of the pod 102 removed from the top cap 115 and pod housing 110, for illustrative purposes only. In embodiments, the storage compartment 112 may be permanently attached to the pod 102 during manufacturing and may have an open top, or fill opening 116, that can be accessed for filling purposes by removing the top cap 115 from the pod 102. FIG. 2B illustrates the pod 102 after full assembly. In both figures, the pod 102 is exploded above the electronic device 104, as may be the case when replacing the pod 102 or changing an operating mode of the system 100, as will be described herein. FIG. 2C illustrates a fully assembled inhalant dispensing system 100, after inserting the pod 102 into a receptacle 117 of the electronic inhalation device 104, as shown in FIG. 1A.

FIG. 3 is a cross-sectional view of a top portion of the inhalant dispensing system 100. As shown, the mouthpiece opening 106 extends into the pod 102 to connect with the open end 116 of the storage compartment 112. The storage compartment 112 comprises a dispensing tube 118 that is in communication with the opening 106 and extends from the open end 116 down through a center of the storage compartment 112. The storage compartment 112 also includes a heating chamber 120 that comprises, or is coupled to, the converter 114. The converter 114 may include an atomizer, a heating coil (e.g., ceramic or metal), a wick, and/or other heating element for converting a substance stored in the storage compartment 112 into vapor. Dispensing tube 118 may be a thin tube or cannula configured to form an air passageway between the heating chamber 120 and the open end 116 of the storage compartment 112. During operation, the heating chamber 120 heats, or vaporizes, the substance stored in the storage compartment 112, and the resulting vapor travels up the dispensing tube 118, out through the open end 116, and ultimately exits through the mouthpiece 106 coupled thereto. The pre-converted substance is stored within the storage compartment 112 in the area around the dispensing tube 118, and is maintained within the pod 102 by the top cap 115. For example, the top cap 115 may include a stopper that is pressed into the fill opening 116 of the storage compartment 112, but includes one or more openings configured to allow only the vaporized substance to exit through the mouthpiece 106.

The storage compartment 112 further comprises one or more exposed electrical contacts 122 adjacent to the bottom end 108 for electrically coupling the converter 114 to the power source 105 included in the electronic device 104. For example, the electrical contacts 122 may include a positive contact 122a and a negative or ground contact 122b that are internally coupled to the converter 114 and have exposed portions (e.g., contact surfaces, pins, connectors, etc.) at the bottom 108 of the pod 102. The electronic inhalation device 104 may include corresponding exposed contacts (e.g., contact surfaces, connectors, pins, etc.) (not shown) within the receptacle 117 that are electrically coupled to the power source 105 and are configured to electrically connect to the electrical contacts 122a and 122b , once the pod 102 is placed within the receptacle 117 and coupled to the electronic device 104. Other techniques for electrically coupling the pod 102 and the electronic device 104 may also be used, such as, for example, inductive coupling.

In some embodiments, the storage compartment 112 further comprises a dispensing mechanism (e.g., dispensing doors) that is configured to selectively open to allow entry of the stored substance into the heating chamber 120. For example, when a user indicates the start of a vaping session (such as, e.g., by pressing a button on the electronic inhalation device 104 or by inhaling through the mouthpiece 106 to trigger an airflow sensor configured to activate the converter 114), the dispensing mechanism (not shown) may open to allow a controlled (or selected) amount of the stored substance to flow into the heating chamber 120, and the converter 114 may be temporarily engaged or activated to convert the substance into an aerosol or mist form. The aerosolized substance is then drawn through the dispensing tube 118 and out the opening 106 by the user. The dispensing mechanism may automatically close once a desired amount of substance has entered the heating chamber 120. Other known forms for converting a substance into a mist could be employed, such as, e.g., using an atomizer or vibration, or ultrasonic wave generator, heating a wick, etc.

The electronic inhalation device 104 can take many forms, and may primarily provide a comfortable holding interface for the user, as well as house the power source 105 and any other electronics for controlling operation of the device 104 and/or the pod 102. In embodiments, the power source 105 may be a battery, such as, for example, a rechargeable lithium-ion battery or a disposable battery. In other embodiments, the power source 105 may be a reusable power source, and the electronic device 104 may include a plug or connector for coupling the device 104 to an external power source, such as, e.g., a wall outlet or a portable battery pack. While the illustrated embodiment has a generally flattened shape, other embodiments may include a circular or cylindrical shape, a rectangular or box-like shape, etc.

FIG. 2C shows the pod 102 properly loaded into the receptacle 117 of the electronic inhalation device 104. During use, the mouthpiece 106 is placed into a user's mouth. In some embodiments, the user must press an actuator to trigger the heating element of the converter 114. In other embodiments, the user simply intakes air, or inhales, through the mouthpiece 106, which triggers airflow sensors coupled to the pod 102 and configured to activate the converter 114 upon detecting airflow. The user then draws aerosol through the dispensing tube 118 and out the mouthpiece 106 by inhaling.

The electronic inhalation device 104 includes a control system 124 in addition to the power source 105. The control system 124 may be in electronic communication with the converter 114, via the contacts 122, and may be configured to control operation of the heating element and/or dispensing mechanism, if any, within the converter 114. As such, the control system 124 may control whether and how much substance or vapor is dispensed. In some embodiments, the control system 124 is also configured to carry out “smart” operations of the electronic device 104. For example, the control system 124 may record information about any dosage dispensed by the pod 102 into a memory chip, such as, e.g., the amount of solution dispensed and the time it was dispensed. The stored information may be communicated, via a communications module of the control system 124, to a mobile device of the user. For example, the electronic inhalation device 104 may be in wireless communication with an application that presents a user interface to the user, such as on a smartphone, tablet, or other computer device, or to a user account accessible via the internet, such that the user (or medical professionals, etc.) may interface with logic contained within the device 104 to tailor dosages and provide for permissions on dispensing aerosol solution to the user. In some cases, a memory element of the electronic inhalation device 104 may be loaded with information specific to the user or owner of the inhalant dispensing system 100, which may be used to provide the tailored dosages. The control system 124 may be implemented on one or more printed circuit boards (PCBs) comprising the components of the control system 124, including, for example, the processor, the memory element, and the communications module.

In some embodiments, the pod 102 is also a “smart” device and includes a memory component, such as, e.g., an RFID or NFC chip, a barcode, or a QR code, that stores information about the substance included in the storage compartment 112 of the pod 102, including, for example, particular strain information, chemical properties, form, viscosity, blend of materials (such as, e.g., cannabis extracts, terpenes, nutraceuticals, essential oils, or cannabinoids), information on appropriate usage, effectiveness, or side effects, and/or other identifying data related to the substance. In such cases, the communications module of the control system 124 includes a reader to read the information from the memory component of the pod 102. The control system 124 may also include a processor to process dosage instructions and other data, retrieve information from the memory element and/or communications module, and provide instructions to the pod 102 as to any controls that should be placed on the amount of substance to be dispensed, the duration of a vaping session, the temperature to which the converter 114 is heated, the length of time the converter 114 is heated, etc. For example, the processor could use the substance identifying information to adjust the heating temperature, length of heating time, and other dispensing characteristics of the pod 102 to maximize effectiveness of the substance or obtain a desired effectiveness. The communications module of the electronic device 104 could also be used to convey information to the user's mobile device about a number of dosages left in the pod 102. When the dosage is running low, the mobile application on the user's device could automatically place an order for a new pod.

Referring back to FIG. 3, the inhalant dispensing system 100 further includes a mode selection system 200 (also referred to therein as a “mode selector”) configured to enable user selection of an operating mode for the system 100, in accordance with embodiments. In the illustrated embodiment, the mode selection system 200 includes a first contact 202 (also referred to herein as a “first component”) disposed in the pod 102, adjacent to the flat bottom 108, and a second contact 204 (also referred to herein as a “second component”) disposed in the electronic device 104, adjacent to a receiving surface 126 of the receptacle 117. When the two contacts 202 and 204 are aligned, or disposed on the same side, as shown in FIG. 3, a first operating mode may be initiated. When the two are not aligned, or disposed on opposite sides, as shown in FIG. 1E, a second operating mode may be initiated. In embodiments, “alignment” may be determined based on proximity, physical contact, and/or electrical connection between the two contacts 202 and 204.

As shown in FIGS. 1A through 1E, the user may switch between the two modes by changing an orientation of the pod 102 relative to the electronic device 104, or an arrangement of the contacts 202 and 204 relative to each other. For example, in FIGS. 1A and 1B, the pod 102 is coupled to the electronic device 104 so that both contacts 202 and 204 are disposed on a left-side of the system 100, or in a first orientation. This alignment of the two contacts 202 and 204 places the system 100 in the first operating mode. In FIG. 1C, the pod 102 has been removed from the electronic device 104 and rotated 180 degrees, so that the first contact 202 moves from the left-side position to a right-side position, or to a second orientation. In FIG. 1D, the electronic device 104 remains in the first orientation as the pod 102 is lowered into the receptacle 117 while in the second orientation. FIG. 1E shows the pod 102 fully coupled to the electronic device 104 with the two components in different orientations. In such cases, the first contact 202 is no longer arranged in alignment with the second contact 204, as the two contacts are situated on opposite sides of the system 100. This non-alignment of the contacts 202 and 204 places the system 100 in the second operating mode.

As shown in FIG. 3, in some embodiments, the first contact 202 may include left and right contact pins, and the second contact 204 may include corresponding left and right spring contacts (also referred to as “spring fingers” or “clips”) configured to electrically connect to the first and second contact pins of the first contact 202, respectively, upon contact. In some embodiments, the control system 124 may be configured to detect the electrical connection between contacts 202 and 204 and in response, initiate the first operating mode associated with the first, or aligned, orientation shown in FIG. 3. In other embodiments, the mode selection system 200 may be configured to send a signal to the control system 124 to indicate the operating mode associated with a current orientation of the pod 102. In one embodiment, the mode selection system 200 may send a signal only when the contacts 202 and 204 are aligned in the first orientation. In such cases, the control system 124 triggers the first operating mode when the signal is received from the mode selection system 200, and if the signal is not received, the control system 124 automatically sets the system 100 to the second operating mode.

Other techniques may be used to determine the orientation of the pod 102 relative to the electronic device 104, and/or the arrangement (e.g., alignment or non-alignment) of the contacts 202 and 204 relative to each other. For example, instead of electrical contacts 202 and 204, the mode selection system 200 may include mechanical pins to indicate alignment or non- alignment of the pod 102 and the electronic device 104. In other exemplary embodiments, the mode selection system 200 may include a proximity sensor or other device configured to detect when the contacts 202 and 204 are aligned, or not aligned. In one example embodiment, the second contact 204 may be, or may include, a proximity sensor configured to detect an orientation of the pod 102 based on whether the first contact 202 is adjacent, or in close proximity to, the second contact/proximity sensor 204. In such case, if the second contact/proximity sensor 204 detects the presence of the first contact 202, the mode selection system 200 may determine that the pod 102 is in the first orientation, and if the second contact 204 does not detect the first contact 202, the mode selection system 200 may determine that the pod 102 is in the second orientation. In the above embodiments, the mode selection system 200 may send a signal to the control system 124 to indicate the selection of a particular operating mode, the detection of a particular orientation, and/or the presence of an alignment or non- alignment.

In other embodiments, the mode selection system 200 can include an actuator, button, switch, toggle, slider, or other input device configured to physically toggle between the first and second operating modes, or otherwise enable physical selection of a specific operating mode without changing an orientation of the pod 102. In still other embodiments, the mode selection system 200 may include a digital user interface for selecting a given operating mode that is displayed on the electronic device 104 itself, on the pod 102 itself, or on the mobile device wirelessly communicating with the system 100, by a mobile application.

The selectable operating modes may vary depending on the particular system 100, the type of substance delivery component 102, and/or the type of electronic inhalation device 104. In a preferred embodiment, the operating modes include at least a beginner or novice mode configured to control, monitor, measure, and/or track dosing for more inexperienced users, and an expert or professional mode configured to allow substantially uninhibited use for more experienced users. Also in one preferred embodiment, the first orientation, or when the contacts 202 and 204 are aligned and/or in contact, corresponds to, or activates, the expert mode, and the second orientation, or when the contacts 202 and 204 are not aligned, corresponds to, or activates, the beginner mode. Though two selectable modes are described herein, the mode selection system 200 may be configured to allow for selection between more than two modes of operation, for example, using other mode selection techniques (e.g., a physical or digital user input device, etc.). Other operating modes are also contemplated, such as, for example, an intermediate mode that allows for somewhat uninhibited use, a recreational mode versus a medicinal mode, and others, all of which are intended to be within the scope of this disclosure.

Certain operating modes may be associated with providing feedback to the user during use of the system 100 and the type of feedback may vary depending on the mode. The feedback may include haptic vibrations, sound cues, and/or light indications, such as, e.g., blinking on and off, changing colors, etc. The feedback may be provided by a feedback module (e.g., feedback module 412 of FIG. 4) included in the control system 124 of the electronic device 104 for providing such indications to the user, as needed. The feedback module may be electronically coupled to the mode selection system 200 in order to receive signals therefrom indicating selection of a particular mode, or alignment of contacts 202 and 204.

In the beginner mode, the electronic device 104 may vibrate, activate a light indicator (e.g., a blinking LED, a specific colored LED, etc.), or otherwise trigger the feedback module to notify the user when a single dose is complete. In some embodiments, a dose is measured based on the amount of substance that is vaporized within the heating chamber 120, or allowed to enter the heating chamber 120. In other embodiments, a dose is measured by the length of a pull or intake, or the amount of time the user inhales (also referred to herein as a “preset length of time”). For example, in one embodiment, a single dose is measured as a pull lasting two seconds. In such cases, the feedback module may be configured to vibrate once the user has finished inhaling vapor for about two seconds. In some embodiments, the feedback module may be configured to keep vibrating every two seconds, for example, if the user continues to inhale or pull in vapor after the first two seconds are complete. In such cases, the vibrations, or other indications, serve as a monitoring tool to help the user keep track of the number of doses being inhaled. In some embodiments, the electronic device 104 may be configured to stop heating or converting the substance after a threshold number of doses have been dispensed with a preset time period (e.g., 12 hours, 24 hours or one day, etc.). In some embodiments, the feedback module may be configured to increase a frequency or intensity of the vibrations (or other indications) after dispensing a threshold number of doses, to warn the user before shutting off the converter 114, for example.

In the expert mode, the feedback module may be configured to continuously vibrate, or provide another indication (e.g., a blinking light or colored light), during the entire intake, so as to provide feedback to the user for the full amount of time that doses are being dispensed. In the expert mode, keeping track of the number of doses may not be a priority, unlike the beginner mode, and therefore, the electronic device 104 may be configured to allow for open-ended or uninhibited usage of the inhalant dispensing system 100 when the expert mode is selected.

In some embodiments, certain parameters of the beginner mode and/or the expert mode may be configured using a mobile application running on the user's mobile device. For example, the user can use the mobile application to customize the length of a dose. For example, the mobile application may be used to increase the length from a default value of two seconds to a customized value of three seconds. The user may also use the mobile application to track intake and usage history and apply this information to control certain feedback settings. For example, in the beginner mode, the mobile application may be used to set the threshold number of uses before the device 104 automatically shuts off the converter 114, thus halting inhalant dispensing. The mobile application may also be used to add or remove feedback settings, such as the auto-shut off feature, the continuous vibration feature in the expert mode, etc.

In some cases, the feedback module can be configured to provide indicative lighting during use of the system 100. For example, the electronic inhalation device 104 may include exterior lighting (e.g., one or more LEDs) that is used to indicate an alert or dispensing problem to the user in an instant fashion, so that consultation with a separate user interface is not required. For example, a yellow light could indicate that a full dosage has been restricted for some reason, a red light could indicate a dosage is not presently available, and a green light indicates a full dosage has been dispensed. More information as to why a red or yellow light shows up could then be accessed via the user interface of the mobile application.

While FIGS. 1A through 3 illustrate one exemplary form of an inhalant dispensing system, it should be appreciated that other forms of substance delivery components and/or electronic inhalation devices can be used to deliver a vaporized substance to a user for inhalation, and such other forms can be configured to include the techniques described herein. For example, the inhalant dispensing system may be configured as a vape pen having a cylindrical shape overall, wherein the substance delivery component is a cylindrical cartridge that can be coupled to a cylindrical electronic inhalation device in one of two orientations for selecting a corresponding one of two operating modes.

FIG. 4 depicts an exemplary inhalant dispensing system 300 configured to receive user selection of one of a plurality of operating modes and operate in accordance with the user-selected mode. The system 300 comprises an electronic inhalation device 400 and a pod 500 capable of wirelessly communicating with the inhalation device 400 for tracking, monitoring, dosing, and/or controlling purposes. The pod 500 may be implemented using the pod 102 described herein, or other substance delivery component in accordance with the techniques described herein. In embodiments, the pod 500 may be a “smart pod” configured to store data that can be read by the inhalation device 400 and used to control various features of the device 400, including dosage control. Likewise, the electronic inhalation device 400 may be implemented using the electronic inhalation device 104 described herein, or other electronic inhalation device in accordance with the techniques described herein. In embodiments, the electronic inhalation device 400 may be a “smart inhalation device” that includes one or more printed circuit boards (PCBs) comprising the control system 124 shown in FIG. 1A, as well as the power source 105.

The pod 500 includes a data module 502 for storing data related to the substance residing inside a storage compartment (e.g., storage compartment 112 shown in FIG. 2A) of the pod 500. The data may include substance identifying information that identifies the exact organic material residing in the pod 500 and a profile of the material. For example, the substance identifying information may include specific strain, formulation, and/or blend information, including CBD levels, THC levels, strain name, potency, terpene profile, cannabinoid profile, and/or ratio of psychoactive vs. non-psychoactive chemicals. In some cases, the substance identifying information may be pre-loaded onto the data module 502 by the original manufacturer in a product filling line (e.g., in the case of disposable cartridges). In other cases, the substance identifying information may be added or uploaded to the data module 502 at the time of filling or re-filling the pod 500 with a substance by the user or dispensary that performs the filling. In some embodiments, the data module 502 also stores product preparation information specific to the substance stored in the storage compartment of the pod 500, such as, e.g., mixing or shaking requirements, heating temperature, heating time, etc. In other embodiments, this product preparation information is retrieved by the inhalation device 400 in response to receiving the substance identifying information from the pod 500.

The data module 502 can include an RFID tag, a near-field communication (NFC) chip, a QR code, a barcode, or other identification device capable of storing the substance identifying information and being read by, or otherwise providing this information to, the electronic inhalation device 400. In some cases, the data module 502 is embedded in or included on a printed label (e.g., adhesive sticker or decal) or other object that is attached to an outer surface of the pod 500. In other cases, the data module 502 may be etched onto or otherwise embedded into the pod 500 itself, for example, in the case of a QR code or barcode. In still other cases, the data module 502 may be included in a separate component that is attached to the pod 500, such as, for example, a data cap.

In some embodiments, the pod 500 includes a memory module 504 for storing the substance identifying information and/or other data, and a communications module 506 for providing the stored data to the electronic inhalation device 400 and/or otherwise communicating with the device 400. The communications module 506 may be configured to transmit data from the memory module 504 to the inhalation device 400 using one or more wired or wireless technologies. In some cases, the communications module 506 may also be configured to receive data for storing in the memory module 504. The communications module 506 may comprise one or more transceivers, ports, modems, or other communications devices for facilitating communications using Bluetooth, NFC, Wi-Fi, or other wireless communications technology. In some cases, the pod 500 also includes a processor (e.g., microprocessor) to carry out one or more functions using software instructions stored in the memory module 504 and/or received via the communications module 506.

In some cases, the memory module 504 and communications module 506 are included in the pod 500 instead of the data module 502 for storing and communicating the substance identifying information. In other cases, the memory module 504 is configured to store data other than the substance identifying information stored in the data module 502, and the communications module 506 is for communicating only the data stored in the memory module 504, separate from the communication between the data module 502 and the inhalation device 400. As will be appreciated, other types of short-range wireless communication technology and/or data storage devices may be used to store substance information in the pod 500 and transfer the stored information to the inhalation device 400 or other component for identification, monitoring, tracking, and/or dosing purposes.

The memory module 504 can be configured to store usage data related to the pod 500, including number of doses left, number of doses used, initial number of doses, frequency of use, time of last use, time of each use, etc. The usage data may be used by the pod 500, the electronic inhalation device 400, and/or a mobile device 600 to control operation of the system 300 depending on a selected operating mode, as described herein. In some cases, the usage data provided by the pod 500 may be used to help with ordering or re-ordering of the cartridge from the supplier once product levels are low. For example, usage data stored in the memory module 504 may be used by the supplier to discover which substances are being used more frequently and make recommendations for future orders based on use patterns. In some cases, the memory module 504 stores the product preparation information associated with the substance stored in the pod, such as, e.g., mixing or shaking requirements, heating temperature, heating time, etc.

As shown in FIG. 4, the electronic inhalation device 400 includes at least one processor 402 and at least one memory 404 for storing software that may be executed by the processor 402 to implement one or more functions of the inhalation device 400. The processor 402 may communicate with the memory 404 and any other components of the inhalation device 400 using a data bus (not shown) or other appropriate medium. In embodiments, the processor 402 (e.g., data processor) can comprise one or more of a microprocessor, a microcontroller, a programmable logic array, an application-specific integrated circuit, a logic device, or other electronic device for processing, inputting, outputting, manipulating, storing, or retrieving data.

The inhalation device 400 also includes a power module 406 for powering the device 400. In some cases, the power module 406 includes a battery or other power source that is configured to also supply power to the pod 500 once coupled to the inhalation device 400, such as, e.g., the power source 105 shown in FIG. 1A. In other cases, the power module 406 includes a battery or other power source that is separate from the power source 105 for powering the pod 500.

The inhalation device 400 further includes a communications module 408. In embodiments, the communications module 408 comprises an appropriate data receiver configured to read or receive the substance identifying information and/or other data stored in the data module 502 of the pod 500. For example, the communications module 408 may include an RFID reader, NFC reader, QR code reader, or barcode reader depending on the type of identification device included in the data module 502. The communications module 408 may also be configured to facilitate wireless communications between the inhalation device 400 and an external or remote device, such as, e.g., a mobile device (e.g., smartphone, tablet, laptop, etc.) or other computing device of the user. In some cases, the communications module 408 may also be configured to facilitate wireless communications with the communications module 506 of the pod 500. The communications module 408 of the inhalation device 400 may comprise one or more transceivers, ports, modems, or other communications devices for facilitating such communications using Bluetooth, NFC, Wi-Fi, or other wireless communications technology.

The memory 404 (e.g., data storage device) can comprise one or more of electronic memory, nonvolatile random access memory (e.g., RAM), flip-flops, a computer-writable or computer-readable storage medium, a magnetic or optical data storage device, a magnetic or optical disc drive, a hard disk drive, or other electronic device for storing, retrieving, reading, or writing data. The memory 404 may store one or more software program modules or software instructions for execution by the processor 402. For example, the memory 404 may store a mode selection module 410 comprising software instructions for detecting a user-selected operating mode of the electronic inhalation device 400 and implementing the selected mode, for example, through communication with a feedback module 412, a smart dosing module 414, and/or other components of the system 300.

In embodiments, the mode selection module 410 is configured to receive a signal or other indication of a user-selected mode from the mode selection system 200 shown in FIG. 3, via the processor 402, and in response, instructs the processor 402 to implement the selected mode. In some embodiments, receipt of a signal from the mode selection system 200 indicates placement of the pod 500 in a first orientation (e.g., alignment of the contacts 202 and 204), and non-receipt or absence of a signal from the mode selection system 200 indicates placement of the pod 500 in a second orientation (e.g., non-alignment of the contacts 202 and 204). In such cases, the mode selection module 410 may instruct the processor 402 to activate a first operating mode (e.g., a professional or expert mode) upon receiving the signal, but until then, or so long as a signal is not received from the mode selection system 200, the mode selection module 410 may instruct the processor 402 to activate or maintain a second operating mode (e.g., a beginner mode or default mode). In other embodiments, the mode selection module 410 may be configured to activate the first operating mode upon receiving a first signal from the mode selection system 200 and activate the second operating mode upon receiving a second signal from the mode selection system 200.

To activate or implement the selected operating mode, the mode selection module 410 may send instructions to the feedback module 412, via the processor 402, to activate a haptic device, a light, or other indicator in accordance with the parameters of that mode. For example, in the beginner operating mode, the mode selection module 410 may instruct the feedback module 412 to vibrate after each dose is complete (e.g., every two seconds), and in the expert operating mode, the mode selection module 410 may instruct the feedback module 412 to vibrate continuously for the entire session, or as long as the system 300 is dispensing the vaporized sub stance.

In some embodiments, the mode selection module 410 may be in communication with the pod 500, via the processor 402 and the communications module 408, to obtain current usage data and to send instructions to the pod 500 to stop dispensing the substance after a threshold number of doses have been reached during a given session. The mode selection module 410 may also use the current usage data to determine when to stop providing feedback to the user or otherwise end a selected operating mode. For example, the mode selection module 410 may instruct the feedback module 412 to stop vibrating upon receiving information from the pod 500 indicating that the user has stopped vaping. In other cases, the mode selection module 410 may cease a current operating mode upon receiving appropriate instructions from the mobile device 600 via the communications module 408.

Feedback module 412 (also referred to as an “indicator system”) is included in the electronic inhalation device 400 to convey various types of information related to usage of the inhalation device 400 to the user. In embodiments, the feedback module 412 works in conjunction with the mode selection module 410 to provide appropriate feedback during a selected operating mode, as described herein. The feedback module 412 may also be configured to convey, for example, error messages related to operation of the cartridge, the battery, and/or other aspects of the device 400, a current operating status (e.g., ready to use, in preparation, dose complete, etc.), whether a dose has been completed, low or depleted contents for a given cartridge, low battery power, and/or other notifications related to other detectable condition(s). In the case of multiple cartridges, the feedback module 412 may be configured to indicate or convey which cartridge(s) are currently selected, in use, and/or are available for use.

The feedback module 412 can include one or more lights (e.g., light-emitting diodes (LEDs)), haptic devices (e.g., a vibrating motor or actuator), audio devices (e.g., a speaker or tweeter), and/or display devices (e.g., a touchscreen or LCD). In some embodiments, the feedback module 412 includes a haptic device configured to provide dynamic feedback to the user during a vaping session, as described herein,. For example, in accordance with the beginner operating mode, the haptic device may be configured to vibrate when a single dose is complete and/or each time the user has completed a dose, where a dose comprises a pre-determined amount or content of vaporized liquid and/or corresponds to a pull or inhale lasting a predetermined length of time (e.g., about two seconds). The feedback module 412 may be in communication with the processor 402 and the memory 404, as well as other components of the device 400, in order to carry out its operations.

In some embodiments, the memory 404 also stores smart dosing module 414, which comprises software instructions for retrieving substance identifying information from the pod 500 or otherwise identifying the pod 500, tracking usage of the pod 500 and/or the inhalation device 400, monitoring doses and controlling dosage during use of the inhalation device 400, controlling heating temperature, heating time, and length of puff or other dosage amount during use of the pod 500 in accordance with one or more pre-determined settings, and/or implementing customized settings received from a mobile device or a software application running thereon, using the techniques described herein. In such cases, the smart dosing module 414 may communicate with or provide instructions to the pod 500, or more specifically, the converter 114 and/or delivery system of the pod 500, in order to carry out one or more dosage-related functions. In some embodiments, the smart dosing module 414 works in conjunction with the mode selection module 410 and/or the feedback module 412 to implement a user-selected operating mode.

In some embodiments, the memory 404 stores a program module or software instructions, as part of the smart dosing module 414 or separately, for automatically adjusting certain settings of the pod 500 and/or the inhalation device 400 based on the substance identifying information retrieved from the data module 502. For example, the memory 404 may include a database comprising pre-determined settings for each strain, blend, or other type of product on the market. In other embodiments, the pre-determined settings database may be stored in a cloud server (not shown) and may be accessed by the inhalation device 400 (or smart dosing module 414) using the communications module 408 and the processor 402, in response to receiving substance identifying information from the pod 500.

In some embodiments, the pre-determined settings may be material-specific settings that are based solely on the organic material included in the pod 500 and its profile and therefore, may be considered “universal” settings (e.g., as opposed to customized settings). One pre-determined setting may be heat, or a recommended temperature to use when heating the substance (e.g., using the heating element of the pod 500) to avoid burning or undercooking the substance. Another pre-determined setting may be duration, or a recommended length of time to heat the substance. For example, an oil or other solution may not require as long to heat up as a flower or dry herb. The pre-determined settings may also include dose, or a recommended dosage amount for that particular substance. In some cases, a single dose is characterized as an amount or volume of the substance. In other cases, a single dose is measured by the length of the draw, or how long the user intakes or inhales from the device (e.g., 2 seconds or 2.5 seconds). The accurate dosage amount and type for a given substance may vary, depending on the type of strain or organic material and its profile (e.g., concentration, potency, chemical makeup, etc.). In some embodiments, the predetermined settings may be used to determine when to provide a dosage indication via the feedback module 412, for example, through vibrations generated by a haptic motor or light pulses emitted by an LED. The pre-determined settings may include other recommended settings that are specific to the particular strain or substance residing in the pod 500. The recommended settings may be determined by the manufacturer, factory, dispensary, or other supplier of the substance.

In some cases, the pre-determined settings further include preset profiles for tailoring the settings according to an experience level of the user. For example, the preset profiles may include a “light” or “novice” profile for setting the heating element to a lower temperature and heating the substance for a shorter heat time and/or taking a smaller dose, as compared to the recommended settings described above. The preset profiles may also include a “strong” or “advanced” profile for setting the heating element to a higher temperature and heating the substance for a longer heat time and/or taking a larger dose, compared to the recommended settings. The preset profiles may further include a recommended or regular setting for implementing the recommended heat, duration, and dose settings for that particular substance. The preset profiles may be pre-stored in the smart dosing module 414 or retrieved by the processor 402 via the communications module 408 from a remote database, like the other pre- determined settings.

As shown in FIG. 4, the inhalation device 400 can be configured to wirelessly communicate with a mobile device 600 of the user. The mobile device 600 may be a smartphone, tablet, laptop, or other computing device capable of wirelessly communicating with the inhalation device 400. The mobile device 600 may include all or a portion of a software application 602 for controlling, monitoring, and/or tracking use of the inhalation device 400 and a display screen 604 (e.g., touchscreen and/or other display device) for displaying information generated by the software application 602 or otherwise related to the pod 500 and/or the inhalation device 400, and in some cases, for enabling user interaction with the software application 602.

Though not shown, the mobile device 600 may include at least one processor (e.g., microprocessor), memory element (e.g., electronic memory), and communications module (comprising, e.g., one or more wireless transceivers, modems, antennas, etc.) configured to implement various features of the software application 602. In particular, all or portions of the software application 602 may be stored in the memory, along with other data related to, or received from, the inhalation device 400. The processor may be configured to execute the software application 602 and present a user interface on the display screen 604. The user interface may be configured to enable user selection or customization of certain settings for the inhalation device 400, such as, for example, the operating modes described herein and/or the preset profiles described herein. The user interface may also be configured to enable the user to enter certain information, such as, e.g., genetic profile data, personal preferences of the user, user history data, etc. The communications module may be configured to communicate with the inhalation device 400 using, for example, Bluetooth, WiFi, or other wireless communication technology. In some embodiments, the mobile device 600 may use the communications module to access data and/or portions of the software application 602 that are stored remotely (e.g., in a cloud server).

The mobile application 602 can be configured to cooperate with the mode selection module 410 and/or the smart dosing module 414 of the inhalation device 400 in order to carry out one or more operations related to selecting and implementing an operating mode of the smart inhalation device 400, and tracking, monitoring, and/or controlling use of the inhalation device 400 or the pod 500 installed therein. For example, the mobile application 602 may be used to customize certain settings for the plurality of operating modes, including, for example, the amount of time that represents a single dose for feedback purposes, a maximum number of doses allowed before automatic shut-off is initiated, etc.

As another example, in some embodiments, the smart dosing module 414 controls or adjusts one or more settings of the inhalation device 400 and/or the pod 500 (e.g., heat, duration, and dose) based on customized settings received from the mobile application 602. In some cases, the smart dosing module 414 provides the pre-determined material-specific settings to the software application 602, and the software application 602 further customizes or adjusts these settings based on user profile information provided by the user or otherwise obtained by the software application 602. In other cases, the software application 602, itself, identifies the pre-determined material-specific settings based on the substance identifying information obtained from the pod 500 by the inhalation device 400, and the smart dosing module 414 applies the settings received from the mobile device 600. In other embodiments, the processor 402 may use the smart dosing module 414 to automatically select and apply the pre-determined settings that are specific to the substance identified by the received data, until or unless the software application 602 provides customized use settings.

In some embodiments, the user profile information that may be used to customize settings for the inhalation device 400 can include genetic profile data obtained from a third-party, such as, e.g., 23andMe®. The genetic profile data may be used by the software application 602 to make personalized recommendations, such as, for example, which strains are best suited for the user, or is most likely to provide a desired effect, based on the user's genetic profile. In some embodiments, the user profile information may also include user preferences entered by the user, such as, e.g., preferred heating profile (e.g., temperature and heat time) for a specific strain, preferred dosage amount for a specific strain, preferred time of day (e.g., night or day) to use either a particular strain or any substance, desired effects when vaping (e.g., pain relief, relaxation, anxiety-relief, etc.), the user's experience-level to help select one of the preset profiles, and others. In some embodiments, the software application 602 and/or the smart dosing module 414 are configured to learn user preferences over time, including what the user likes and doesn't like, which dose of a given strain produces optimal effects for that user, etc., and store this learned information in the user profile information.

In some embodiments, the software application 602 can also cooperate with the smart dosing module 414 to track and monitor use of the inhalation device 400 and/or pod 500. For example, the smart dosing module 414 may record the number of puffs or doses taken during a given use or session, the time of day for each session, frequency of uses or amount of time between sessions, and/or other information related to tracking and monitoring use. In some cases, this information may be provided, at least in part, to the mode selection module 410 to determine when to stop providing feedback or when to stop vaping operation. In other cases, the software application 602 may work with the mode selection module 410 to control or prevent usage of the inhalation device 400 if a threshold number of doses have been reached for the day or within a set time period. The tracking information may also be used to recommend products to the user or remind the user when it's time to order another cartridge.

Thus, the techniques described herein provide an inhalant dispensing system that enables a user to select from a plurality of operating modes designed to reflect the user's experience level by simply changing an orientation of the substance delivery component relative to the electronic inhalation device configured to receive the same. In addition, the system can provide users with a customized vaping experience that is tailored to the particular user and, in some cases, the particular substance to be vaporized, by combining material-specific settings (e.g., heat, duration, dose, etc.), which are pre-determined or standardized for the substance contained in a given cartridge, with user-specific settings (e.g., recommended strains, genetic profile, user-entered preferences, learned preferences, user history, etc.), which are unique to each user.

It will be understood by those skilled in the art that various changes may be made and equivalents may be substituted without departing from the scope of the novel and non-obvious techniques disclosed in this application. Therefore, it is intended that the novel teachings of the present invention not be limited to the particular embodiment disclosed, but that they will include all embodiments falling within the scope of the appended claims.

INHALANT DISPENSING SYSTEM AND APPARATUS WITH BINARY DOSING

Information

Publication Number

Date Filed

Date Published

Inventors

Original Assignees

CPC

International Classifications

Abstract

Description

Claims

CROSS-REFERENCE

Provisional Applications (1)